UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Common Shares Held in Treasury	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021			95,746,975
Beginning balance at Dec. 31, 2021	$ 709,624	$ (198)	$ 68	$ 916,578	$ (897)	$ (206,218)	$ (198)	$ 93
Beginning balance (in shares) at Dec. 31, 2021					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,112
Common stock issued for exercise of employee stock options (in shares)			8,486
Common stock issued for exercise of employee stock options	80			80
Issuance of restricted shares, net of forfeitures (in shares)			533,095
Issuance of restricted shares, net of forfeitures	0		$ 5	(5)
Stock-based compensation	5,108			5,108
Net income	6,236					6,236
Foreign currency translation adjustment, net of tax				(8)				283
Foreign currency translation adjustment, net of tax	275
Ending Balance (in shares) at Mar. 31, 2022			96,289,668
Ending Balance at Mar. 31, 2022	721,125		$ 73	921,753	$ (897)	(200,180)		376
Ending balance (in shares) at Mar. 31, 2022					107,820
Beginning balance (in shares) at Dec. 31, 2021			95,746,975
Beginning balance at Dec. 31, 2021	709,624	$ (198)	$ 68	916,578	$ (897)	(206,218)	$ (198)	93
Beginning balance (in shares) at Dec. 31, 2021					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	27,110
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(7,990)
Ending Balance (in shares) at Sep. 30, 2022			96,548,066
Ending Balance at Sep. 30, 2022	748,214		$ 75	936,239	$ (897)	(179,306)		(7,897)
Ending balance (in shares) at Sep. 30, 2022					107,820
Beginning balance (in shares) at Mar. 31, 2022			96,289,668
Beginning balance at Mar. 31, 2022	721,125		$ 73	921,753	$ (897)	(200,180)		376
Beginning balance (in shares) at Mar. 31, 2022					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,812
Common stock issued for exercise of employee stock options (in shares)			76,399
Common stock issued for exercise of employee stock options	734			734
Issuance of restricted shares, net of forfeitures (in shares)			42,388
Stock-based compensation	6,023			6,023
Net income	11,571					11,571
Foreign currency translation adjustment, net of tax				(24)				(3,483)
Foreign currency translation adjustment, net of tax	(3,507)
Ending Balance (in shares) at Jun. 30, 2022			96,410,267
Ending Balance at Jun. 30, 2022	735,946		$ 73	928,486	$ (897)	(188,609)		(3,107)
Ending balance (in shares) at Jun. 30, 2022					107,820
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,604
Common stock issued for exercise of employee stock options (in shares)			159,350
Common stock issued for exercise of employee stock options	1,479		$ 2	1,477
Issuance of restricted shares, net of forfeitures (in shares)			(23,155)
Stock-based compensation	6,293			6,293
Net income	9,303					9,303
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(4,790)			(17)				(4,790)
Foreign currency translation adjustment, net of tax	(4,807)
Ending Balance (in shares) at Sep. 30, 2022			96,548,066
Ending Balance at Sep. 30, 2022	$ 748,214		$ 75	936,239	$ (897)	(179,306)		(7,897)
Ending balance (in shares) at Sep. 30, 2022					107,820
Beginning balance (in shares) at Dec. 31, 2022	96,717,883		96,717,883
Beginning balance at Dec. 31, 2022	$ 736,646		$ 76	942,789	$ (14,859)	(186,448)		(4,912)
Beginning balance (in shares) at Dec. 31, 2022	1,047,237				1,047,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			4,567
Repurchases of common stock (in shares)			493,926		493,926
Repurchases of common stock	$ (7,712)				$ (7,712)
Issuance of restricted shares, net of forfeitures (in shares)			1,894,310
Issuance of restricted shares, net of forfeitures	0		$ 19	(19)
Shares withheld to cover restricted share vesting tax (in shares)			(37,128)		(37,128)
Shares withheld to cover restricted share vesting tax	(487)				$ (487)
Stock-based compensation	8,043			8,043
Net income	591					591
Unrealized gain (loss) on hedged transactions, net of tax	(5,159)							(5,159)
Foreign currency translation adjustment, net of tax	682							682
Ending Balance (in shares) at Mar. 31, 2023			98,085,706
Ending Balance at Mar. 31, 2023	$ 732,604		$ 95	950,813	$ (23,058)	(185,857)		(9,389)
Ending balance (in shares) at Mar. 31, 2023					1,578,291
Beginning balance (in shares) at Dec. 31, 2022	96,717,883		96,717,883
Beginning balance at Dec. 31, 2022	$ 736,646		$ 76	942,789	$ (14,859)	(186,448)		(4,912)
Beginning balance (in shares) at Dec. 31, 2022	1,047,237				1,047,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common stock (in shares)	3,523,838
Repurchases of common stock	$ (46,000)
Net income	3,268
Unrealized gain (loss) on hedged transactions, net of tax	1,554
Foreign currency translation adjustment, net of tax	$ (269)
Ending Balance (in shares) at Sep. 30, 2023	95,045,289		95,045,289
Ending Balance at Sep. 30, 2023	$ 720,741		$ 97	971,950	$ (64,499)	(183,180)		(3,627)
Ending balance (in shares) at Sep. 30, 2023	4,843,938				4,843,938
Beginning balance (in shares) at Mar. 31, 2023			98,085,706
Beginning balance at Mar. 31, 2023	$ 732,604		$ 95	950,813	$ (23,058)	(185,857)		(9,389)
Beginning balance (in shares) at Mar. 31, 2023					1,578,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			2,363
Repurchases of common stock (in shares)			1,465,893		1,465,893
Repurchases of common stock	(17,630)				$ (17,630)
Common stock issued for exercise of employee stock options (in shares)			63,336
Common stock issued for exercise of employee stock options	611			611
Issuance of restricted shares, net of forfeitures (in shares)			80,331
Issuance of restricted shares, net of forfeitures	0		$ 1	(1)
Shares withheld to cover restricted share vesting tax (in shares)			(7,181)		(7,181)
Shares withheld to cover restricted share vesting tax	(85)				$ (85)
Stock-based compensation	9,358			9,358
Net income	323					323
Unrealized gain (loss) on hedged transactions, net of tax	4,751							4,751
Foreign currency translation adjustment, net of tax	955							955
Ending Balance (in shares) at Jun. 30, 2023			96,758,662
Ending Balance at Jun. 30, 2023	$ 730,887		$ 96	960,781	$ (40,773)	(185,534)		(3,683)
Ending balance (in shares) at Jun. 30, 2023					3,051,365
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common stock (in shares)	1,564,019		1,564,019		1,564,019
Repurchases of common stock	$ (20,701)				$ (20,701)
Common stock issued for exercise of employee stock options (in shares)			165,422
Common stock issued for exercise of employee stock options	1,387		$ 2	1,385
Issuance of restricted shares, net of forfeitures (in shares)			(86,222)
Issuance of restricted shares, net of forfeitures	0		$ (1)	1
Shares withheld to cover restricted share vesting tax (in shares)			(228,554)		(228,554)
Shares withheld to cover restricted share vesting tax	(3,025)				$ (3,025)
Stock-based compensation	9,783			9,783
Net income	2,354					2,354
Unrealized gain (loss) on hedged transactions, net of tax	1,962							1,962
Foreign currency translation adjustment, net of tax	$ (1,906)							(1,906)
Ending Balance (in shares) at Sep. 30, 2023	95,045,289		95,045,289
Ending Balance at Sep. 30, 2023	$ 720,741		$ 97	$ 971,950	$ (64,499)	$ (183,180)		$ (3,627)
Ending balance (in shares) at Sep. 30, 2023	4,843,938				4,843,938